AGIOS PHARMACEUTICALS
Live / Registered — Registered (as of 28 Feb 2023)
What this means for you
Registered since 28 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97108511
- Registration number
- 6993175
- Mark type
- Stylized text
- Filed
- 04 Nov 2021
- Published for opposition
- 27 Sept 2022
- Registered
- 28 Feb 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
Owner
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 28 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2022 — USE AMENDMENT FILED
- 25 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 22 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Sept 2022 — PUBLISHED FOR OPPOSITION
- 07 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Aug 2022 — ASSIGNED TO EXAMINER
- 09 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED